Articles with public access mandates - Sophia RanLearn more
Not available anywhere: 1
IRF5 is a novel regulator of CXCL13 expression in breast cancer that regulates CXCR5+ B and T cell trafficking to tumor-conditioned media.
E Pimenta, S De, R Weiss, D Feng, K Hall, S Kilic, G Bhanot, S Ganesan, ...
Immunology and cell biology 93, 486-499, 2014
Mandates: US National Institutes of Health
Available somewhere: 29
Tumor cell-produced matrix metalloproteinase 9 (MMP-9) drives malignant progression and metastasis of basal-like triple negative breast cancer
C Mehner, A Hockla, E Miller, S Ran, DC Radisky, ES Radisky
Oncotarget 5 (9), 2736, 2014
Mandates: US National Institutes of Health, Susan G. Komen
Lymphangiogenesis and lymphatic metastasis in breast cancer
S Ran, L Volk, K Hall, MJ Flister
Pathophysiology 17 (4), 229-251, 2010
Mandates: US National Institutes of Health
Inflammation induces lymphangiogenesis through up-regulation of VEGFR-3 mediated by NF-κB and Prox1
MJ Flister, A Wilber, KL Hall, C Iwata, K Miyazono, RE Nisato, MS Pepper, ...
Blood, The Journal of the American Society of Hematology 115 (2), 418-429, 2010
Mandates: US National Institutes of Health
Paclitaxel therapy promotes breast cancer metastasis in a TLR4-dependent manner
L Volk-Draper, K Hall, C Griggs, S Rajput, P Kohio, D DeNardo, S Ran
Cancer research 74 (19), 5421-5434, 2014
Mandates: US National Institutes of Health
WNT7A regulates tumor growth and progression in ovarian cancer through the WNT/β-catenin pathway
S Yoshioka, ML King, S Ran, H Okuda, JA MacLean, ME McAsey, ...
Molecular Cancer Research 10 (3), 469-482, 2012
Mandates: US National Institutes of Health
TLR4 is a novel determinant of the response to paclitaxel in breast cancer
S Rajput, LD Volk-Draper, S Ran
Molecular cancer therapeutics 12 (8), 1676-1687, 2013
Mandates: US National Institutes of Health
Macrophage-mediated lymphangiogenesis: the emerging role of macrophages as lymphatic endothelial progenitors
S Ran, KE Montgomery
Cancers 4 (3), 618-657, 2012
Mandates: US National Institutes of Health
The role of TLR4 in chemotherapy-driven metastasis
S Ran
Cancer research 75 (12), 2405-2410, 2015
Mandates: US National Institutes of Health
Semaphorin 3B inhibits the phosphatidylinositol 3-kinase/Akt pathway through neuropilin-1 in lung and breast cancer cells
E Castro-Rivera, S Ran, RA Brekken, JD Minna
Cancer research 68 (20), 8295-8303, 2008
Mandates: US National Institutes of Health
New model of macrophage acquisition of the lymphatic endothelial phenotype
KL Hall, LD Volk-Draper, MJ Flister, S Ran
PLoS One 7 (3), e31794, 2012
Mandates: US National Institutes of Health
Synergy of nab-paclitaxel and bevacizumab in eradicating large orthotopic breast tumors and preexisting metastases
LD Volk, MJ Flister, D Chihade, N Desai, V Trieu, S Ran
Neoplasia 13 (4), 327-IN14, 2011
Mandates: US National Institutes of Health
Macrophage-derived neuropilin-2 exhibits novel tumor-promoting functions
S Roy, AK Bag, S Dutta, NS Polavaram, R Islam, S Schellenburg, ...
Cancer Research 78 (19), 5600-5617, 2018
Mandates: US National Institutes of Health, German Research Foundation
E2F1 promotes angiogenesis through the VEGF-C/VEGFR-3 axis in a feedback loop for cooperative induction of PDGF-B
D Engelmann, D Mayoli-Nüssle, C Mayrhofer, K Fürst, V Alla, A Stoll, ...
Journal of molecular cell biology 5 (6), 391-403, 2013
Mandates: US National Institutes of Health
Development of a mouse model for assessing fatigue during chemotherapy
MA Ray, RA Trammell, S Verhulst, S Ran, LA Toth
Comparative medicine 61 (2), 119-130, 2011
Mandates: US National Institutes of Health
Regulation of tumor angiogenesis by the local environment
K Hall, S Ran
Front Biosci 15 (15), 195-212, 2010
Mandates: US National Institutes of Health
Novel Model for Basaloid Triple-negative Breast Cancer: Behavior In Vivo and Response to Therapy
LD Volk-Draper, S Rajput, KL Hall
Neoplasia 14, 926-942, 2012
Mandates: US National Institutes of Health
Lymphatic endothelial progenitors originate from plastic myeloid cells activated by toll-like receptor-4
LD Volk-Draper, KL Hall, AC Wilber, S Ran
PLoS One 12 (6), e0179257, 2017
Mandates: US National Institutes of Health
DW-F5: A novel formulation against malignant melanoma from Wrightia tinctoria
J Antony, M Saikia, V V, LR Nath, MR Katiki, MSR Murty, A Paul, ...
Scientific reports 5 (1), 11107, 2015
Mandates: Council of Scientific and Industrial Research, India
CXM: a new tool for mapping breast cancer risk in the tumor microenvironment
MJ Flister, BT Endres, N Rudemiller, AB Sarkis, S Santarriaga, I Roy, ...
Cancer research 74 (22), 6419-6429, 2014
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program